WeCareAdvisor Study for Caregivers of People Living With Dementia

Summary

The WeCareAdvisor is an online tool to help caregivers manage behavioral and psychological symptoms of people living with dementia. The trial will evaluate its efficacy to reduce caregiver distress, improve confidence managing behaviors, as well as reduce occurrences and severity of behavioral and psychological symptoms.

Visit https://wecareadvisorstudy.com/ for more information.

Conditions

• Dementia
• Caregiver Burnout
• Caregiver Stress Syndrome
• Alzheimer Disease
• Frontotemporal Dementia
• Vascular Dementia
• Dementia With Lewy Bodies

Interventions

BEHAVIORAL

Immediate treatment group with High-Intensity Prompts

Caregivers in the immediate treatment group with high-intensity prompts will use the WeCareAdvisor tool for 6 months. Caregivers will receive telephone and email prompts to use the tool.

BEHAVIORAL

Immediate treatment group with Low-Intensity Prompts

Caregivers in the immediate treatment group with low-intensity prompts will use the WeCareAdvisor tool for 6 months. Caregivers will receive email prompts to use the tool.

BEHAVIORAL

Waitlist Control after three months with High-Intensity Prompts

After 3 months, caregivers will use the WeCareAdvisor tool for 3 months. Caregivers will receive telephone and email prompts. Once the caregiver receives the WeCareAdvisor tool, they will receive a weekly automated email as well as a weekly telephone call from study staff to prompt them to use the tool.

BEHAVIORAL

Waitlist Control after three months with Low-Intensity Prompts

After 3 months, caregivers will use the WeCareAdvisor tool for 3 months. Caregivers will receive email prompts.

Sponsors & Collaborators

• University of California, Davis

  collaborator OTHER

• National Institute on Aging (NIA)

  collaborator NIH

• Johns Hopkins University

  collaborator OTHER

• Drexel University

  lead OTHER

Principal Investigators

• Laura N Gitlin, PhD · Drexel University

• Helen C Kales, MD · University of California, Davis

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

FACTORIAL

Eligibility

Min Age

21 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2021-12-13

Primary Completion

2024-07-19

Completion

2024-07-19

Countries

• United States

Study Locations